Market Introduction
A large network of proteins and other molecules that surround, support, and give structure to cells and tissues in the body. The extracellular matrix helps cells attach to, and communicate with, nearby cells, and plays an important role in cell growth, cell movement, and other cell functions. The extracellular matrix is also involved in repairing damaged tissue. Abnormal changes in the extracellular matrix may lead to the development of certain diseases, such as cancer.
Moreover, increasing incidences of trauma and cardiovascular diseases and increasing vascular reconstruction procedures. However, challenges during the usage of decellularized extracellular matrix are expected to restrict the market growth during the forecast period.
The US-registered highest number of deaths due to the COVID-19 pandemic. The chaotic situation was created in the medical industry across the countries, increased demand for diagnosing and therapeutic devices have dramatically increased in the hospitals. For instance, the demand for ventilators, respirators, and in vitro diagnostic (IVD) tests has risen drastically in hospitals across the countries in the region. The FDA has increased its efforts to support the health of people and has imposed several guidelines and for hospitals and medical device companies. Various companies also enhanced their research and development activities for diagnostics tests and therapeutic devices. Although the healthcare sector had witnessed SARS, H1N1, and other outbreaks in the last few years, the severity of the COVID-19 has made the situation more complicated due to its mode of transmission. North America has been witnessing a growing number of COVID-19 cases since its outbreak.
Market Overview and Dynamics
The North America extracellular matrix market is expected to reach US$ 20,111.6 Thousands by 2028 from US$ 12,163.1 Thousands in 2021. The market is estimated to grow at a CAGR of 7.4% from 2021–2028. Developing nations are significantly improving their healthcare facilities and services and are heading toward technological advancements. With increasing manufacturing costs against their practices, medical device manufacturers are struggling to generate enough revenue to please their investors. These economies are conducting enormous conferences and research activities for the extracellular matrix. The emerging markets in developing economies are expected to offer better and lucrative growth opportunities for leading players to expand their business and geographic reach. Several emerging nations are spending heavily on the development biotechnology sector of the healthcare industry. The market is consolidating with several local and multinational players engaged in R&D for various technologies in the biotechnology sectors. Thus, the market is likely to show significant growth opportunities during the forecast period due to the factors mentioned above.
Key Market Segments
In terms of raw material, the porcine segment accounted for the largest share of the North America extracellular matrix market in 2020. In terms of application, the soft tissue repair segment accounted for the largest share of the North America extracellular matrix market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the extracellular matrix market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Medtronic, Merck Kgaa, Mtf Biologics, Smith & Nephew, Anteris, Aziyo, Coloplast Group, Baxter, DSM, and Cook Biotech.
Reasons to Buy Report
NORTH AMERICA EXTRACELLULAR MATRIX MARKET SEGMENTATION
By Raw Material
By Application
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 12,163.1 thousand |
| Market Size by 2028 | US$ 20,111.6 thousand |
| CAGR (2021 - 2028) | 7.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Raw Material
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Extracellular Matrix Market is valued at US$ 12,163.1 thousand in 2021, it is projected to reach US$ 20,111.6 thousand by 2028.
As per our report North America Extracellular Matrix Market, the market size is valued at US$ 12,163.1 thousand in 2021, projecting it to reach US$ 20,111.6 thousand by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.
The North America Extracellular Matrix Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Extracellular Matrix Market report:
The North America Extracellular Matrix Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Extracellular Matrix Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Extracellular Matrix Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Extracellular Matrix Market
